Articles

1. Targeting KRAS-Mutated Gastrointestinal Malignancies with Small-Molecule Inhibitors: A New Generation of Breakthrough Therapies

   • Bennett A. Caughey
   • John H. Strickler

   Review Article 18 December 2023 Pages: 27 - 44

   

2. Vamorolone: First Approval

   • Susan J. Keam

   AdisInsight Report 16 December 2023 Pages: 111 - 117

   

3. Pharmacological Treatments of Temporomandibular Disorders: A Systematic Review Including a Network Meta-Analysis

   • Nikolaos Christidis
   • Essam Ahmed Al-Moraissi
   • Malin Collin

   Systematic Review Open access 16 December 2023 Pages: 59 - 81

   

4. Zilucoplan: First Approval

   • Matt Shirley

   AdisInsight Report Open access 14 December 2023 Pages: 99 - 104

   

5. New Therapies on the Horizon for Primary Biliary Cholangitis

   • Atsushi Tanaka

   Leading Article 12 December 2023 Pages: 1 - 15

   

6. Gepirone Extended-Release: First Approval

   • Susan J. Keam

   AdisInsight Report 11 December 2023 Pages: 1723 - 1728

   

7. HIV Pre-Exposure Prophylaxis: New and Upcoming Drugs to Address the HIV Epidemic

   • Christina G. Rivera
   • John D. Zeuli
   • Zelalem Temesgen

   Review Article 11 December 2023 Pages: 1677 - 1698

   

8. Correction to: Motixafortide: First Approval

   • Sheridan M. Hoy

   Correction 07 December 2023 Pages: 1737 - 1737

9. Nedosiran: First Approval

   • Yahiya Y. Syed

   AdisInsight Report Open access 07 December 2023 Pages: 1729 - 1733

   

10. Efficacy and Safety of the Travoprost Intraocular Implant in Reducing Topical IOP-Lowering Medication Burden in Patients with Open-Angle Glaucoma or Ocular Hypertension

    • John P. Berdahl
    • Steven R. Sarkisian Jr
    • the Travoprost Intraocular Implant Study Group

    Original Research Article Open access 07 December 2023 Pages: 83 - 97

    

11. Waldenström Macroglobulinemia: Targeted Agents Taking Center Stage

    • Shayna Sarosiek
    • Jorge J. Castillo

    Review Article 06 December 2023 Pages: 17 - 25

    

12. Acknowledgement to Referees

    Acknowledgement to Referees 02 December 2023 Pages: 1645 - 1647

13. Iruplinalkib: First Approval

    • Susan J. Keam

    AdisInsight Report 27 November 2023 Pages: 1717 - 1721

    

14. Correction: Elacestrant: First Approval

    • Sheridan M. Hoy

    Correction Open access 25 November 2023 Pages: 1735 - 1735

15. Motixafortide: First Approval

    • Sheridan M. Hoy

    AdisInsight Report 23 November 2023 Pages: 1635 - 1643

    

16. Mitapivat: A Review in Pyruvate Kinase Deficiency in Adults

    • Amy Zhuang-Yan
    • Matt Shirley

    Adis Drug Evaluation 22 November 2023 Pages: 1613 - 1620

    

17. Momelotinib: First Approval

    • Susan J. Keam

    AdisInsight Report 21 November 2023 Pages: 1709 - 1715

    

18. Aetiology of Significant Liver Test Abnormalities in a Single-Centre Cohort of People with Cystic Fibrosis Exposed to Elexacaftor/Tezacaftor/Ivacaftor, Utilizing the Updated RUCAM

    • Daniel Tewkesbury
    • Andrew M. Jones
    • Peter J. Barry

    Original Research Article 15 November 2023 Pages: 1699 - 1707

    

19. Sunvozertinib: First Approval

    • Sohita Dhillon

    AdisInsight Report 14 November 2023 Pages: 1629 - 1634

    

20. Elranatamab: First Approval

    • Sohita Dhillon

    AdisInsight Report 04 November 2023 Pages: 1621 - 1627

    

21. Current and Emerging Treatment Options for Uterine Fibroids

    • Mohamed Ali
    • Michał Ciebiera
    • Ayman Al-Hendy

    Review Article 03 November 2023 Pages: 1649 - 1675

    

22. Correction to: Lotilaner Ophthalmic Solution 0.25%: First Approval

    • Yahiya Y. Syed

    Correction Open access 31 October 2023 Pages: 1543 - 1543

23. Zuranolone: First Approval

    • Young-A Heo

    AdisInsight Report 26 October 2023 Pages: 1559 - 1567

    

24. Current and Future Treatment Landscape for Idiopathic Pulmonary Fibrosis

    • Francesco Bonella
    • Paolo Spagnolo
    • Chris Ryerson

    Leading Article Open access 26 October 2023 Pages: 1581 - 1593

25. Correction to: Rozanolixizumab: First Approval

    • Sheridan M. Hoy

    Correction Open access 20 October 2023 Pages: 1569 - 1569

26. Pozelimab: First Approval

    • Sheridan M. Hoy

    AdisInsight Report 19 October 2023 Pages: 1551 - 1557

    

27. Tafolecimab: First Approval

    • Susan J. Keam

    AdisInsight Report 17 October 2023 Pages: 1545 - 1549

    

28. Lotilaner Ophthalmic Solution 0.25%: First Approval

    • Yahiya Y. Syed

    AdisInsight Report Open access 16 October 2023 Pages: 1537 - 1541

    

29. Current Medical Therapy for Adenomyosis: From Bench to Bedside

    • Andrea Etrusco
    • Fabio Barra
    • Antonio Simone Laganà

    Review Article Open access 14 October 2023 Pages: 1595 - 1611

    

30. The Place of Cannabinoids in the Treatment of Gynecological Pain

    • Justin Sinclair
    • Jason Abbott
    • Mike Armour

    Current Opinion Open access 13 October 2023 Pages: 1571 - 1579

31. Emerging Urate-Lowering Drugs and Pharmacologic Treatment Strategies for Gout: A Narrative Review

    • Robert Terkeltaub

    Review Article 11 October 2023 Pages: 1501 - 1521

    

32. Avacincaptad Pegol: First Approval

    • Connie Kang

    AdisInsight Report 09 October 2023 Pages: 1447 - 1453

    

33. Correction to: Ritlecitinib: First Approval

    • Hannah A. Blair

    Correction Open access 05 October 2023 Pages: 1457 - 1457

34. Talquetamab: First Approval

    • Susan J. Keam

    AdisInsight Report 04 October 2023 Pages: 1439 - 1445

    

35. Continued Opioid Use and Adverse Events Following Provision of Opioids for Musculoskeletal Pain in the Emergency Department: A Systematic Review and Meta-Analysis

    • Qiuzhe Chen
    • Chris G. Maher
    • Gustavo C. Machado

    Systematic Review Open access 28 September 2023 Pages: 1523 - 1535

    

36. Befotertinib: First Approval

    • Hannah A. Blair

    AdisInsight Report 26 September 2023 Pages: 1433 - 1437

    

37. Current Understanding of Complement Proteins as Therapeutic Targets for the Treatment of Immunoglobulin A Nephropathy

    • Arun Rajasekaran
    • Todd J. Green
    • Dana V. Rizk

    Review Article 25 September 2023 Pages: 1475 - 1499

    

38. Alcohol-Associated Liver Disease: Evolving Concepts and Treatments

    • David Stephen Prince
    • Emily Nash
    • Ken Liu

    Leading Article Open access 25 September 2023 Pages: 1459 - 1474

    

39. Treatment of Ovarian Cancer Beyond PARP Inhibition: Current and Future Options

    • Vikas Garg
    • Amit M. Oza

    Review Article Open access 22 September 2023 Pages: 1365 - 1385

    

40. Correction to: Birch Bark Extract: A Review in Epidermolysis Bullosa

    • Young-A Heo

    Correction 21 September 2023 Pages: 1455 - 1455

41. Vutrisiran: A Review in Polyneuropathy of Hereditary Transthyretin-Mediated Amyloidosis

    • Tina Nie
    • Young-A Heo
    • Matt Shirley

    Adis Drug Evaluation 20 September 2023 Pages: 1425 - 1432

    

42. Alzheimer’s Disease: Novel Targets and Investigational Drugs for Disease Modification

    • Jeffrey L. Cummings
    • Amanda M. Leisgang Osse
    • Jefferson W. Kinney

    Review Article Open access 20 September 2023 Pages: 1387 - 1408

    

43. Escalation Versus Induction/High-Efficacy Treatment Strategies for Relapsing Multiple Sclerosis: Which is Best for Patients?

    • Gilles Edan
    • Emmanuelle Le Page

    Current Opinion Open access 19 September 2023 Pages: 1351 - 1363

44. Pharmacotherapy for Dravet Syndrome: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials

    • Simona Lattanzi
    • Eugen Trinka
    • Francesco Brigo

    Systematic Review Open access 11 September 2023 Pages: 1409 - 1424

    

45. Correction to: Remdesivir: A Review in COVID-19

    • Hannah A. Blair

    Correction Open access 04 September 2023 Pages: 1349 - 1349

46. Birch Bark Extract: A Review in Epidermolysis Bullosa

    • Young-A Heo

    Adis Drug Evaluation 02 September 2023 Pages: 1309 - 1314

47. Rozanolixizumab: First Approval

    • Sheridan M. Hoy

    AdisInsight Report Open access 01 September 2023 Pages: 1341 - 1347

    

48. Clinical Outcomes with GLP-1 Receptor Agonists in Patients with Heart Failure: A Systematic Review and Meta-analysis of Randomized Controlled Trials

    • Huilei Zhao
    • Yang Liu
    • Jingfeng Wang

    Systematic Review 28 August 2023 Pages: 1293 - 1307

    

49. Pharmacological Management of Orofacial Pain

    • Marcela Romero-Reyes
    • Sherwin Arman
    • Simon Akerman

    Review Article 26 August 2023 Pages: 1269 - 1292

50. Pyoderma Gangrenosum: Treatment Options

    • Joachim Dissemond
    • Angelo V. Marzano
    • Alex G. Ortega-Loayza

    Therapy in Practice Open access 23 August 2023 Pages: 1255 - 1267